Nuclear Imaging Equipment Market Size, Share & Trends Analysis Report By Modality (SPECT, PET), By Application (Cardiology, Oncology), By End-use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2025 - 2030
Fluorescein Angiography Market Growth & Trends
The global fluorescein angiography market size is expected to reach USD 1.39 billion by the end of 2030, expanding at a CAGR of 8.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of ophthalmic conditions such as macular degeneration and diabetic retinopathy and rapid technological advancements are some of the high impact-rendering market drivers. However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.
End-users such as hospitals and imaging centers in the country are effectively adopting AI-based fundus cameras for detecting various blindness-causing diseases. For instance, in January 2019, Deqing County hospital in Guangdong Province conducted a free consultation by featuring an AI camera codeveloped by Sun Yat-sen University and Baidu-a multinational technology company in China that offers services, including a search engine platform-to detect ocular fundus diseases. This AI fundus camera is capable of diagnosing glaucoma, diabetic retinopathy, and macular degeneration.
Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions. The technique provides accurate and high quality pictures which help in selecting efficient treatment regimen. In addition, the demand for tradition fluorescein angiography systems is still high in developing countries. This can be attributed to affordability and product availability.
Fluorescein Angiography Market Report Highlights
- Traditional fluorescein angiography dominated the market and accounted for the largest revenue share of 56.4% in 2024, attributed to the rising incidence of eye diseases, particularly diabetic retinopathy and age-related macular degeneration.
- The age-related macular degeneration (AMD) application held the dominant position in the market, with the largest revenue share of 32.6% in 2024, owing to the increasing prevalence of this condition among the aging population.
- The hospitals and clinics segment led the market and accounted for the largest revenue share of 63.9% in 2024 attributed to the increasing prevalence of eye diseases, particularly among the aging population.
- The fluorescein angiography market in North America dominated the global market and accounted for the largest revenue share of 36.4% in 2024 attributed to the high prevalence of eye diseases, particularly diabetic retinopathy, which affects millions of individuals.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Modality
- 1.2.2. Application
- 1.2.3. End-use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Modality outlook
- 2.2.2. Application Outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Nuclear Imaging Equipment Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing prevalence of cancer
- 3.2.1.2. Technological advancements
- 3.2.1.3. Increasing awareness of diagnostic needs
- 3.2.2. Market restraint analysis
- 3.2.2.1. Stringent regulatory framework
- 3.2.2.2. High cost of procedures
- 3.3. Nuclear Imaging Equipment Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Nuclear Imaging Equipment Market: Modality Estimates & Trend Analysis
- 4.1. Modality Market Share, 2024 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Nuclear Imaging Equipment Market by Modality Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. SPECT
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. PET
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Nuclear Imaging Equipment Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2024 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Nuclear Imaging Equipment Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Cardiology
- 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Oncology
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Neurology
- 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Others
- 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Nuclear Imaging Equipment Market: End-use Estimates & Trend Analysis
- 6.1. End-use Market Share, 2024 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Nuclear Imaging Equipment Market by End-use Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Hospitals
- 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Imaging Centers
- 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. R&D
- 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Others
- 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 7. Nuclear Imaging Equipment Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. North America Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement Scenario
- 7.5.2.5. U.S. Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement Scenario
- 7.5.3.5. Canada Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Europe Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. UK
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement Scenario
- 7.6.2.5. UK Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement Scenario
- 7.6.3.5. Germany Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement Scenario
- 7.6.4.5. France Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement Scenario
- 7.6.5.5. Italy Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement Scenario
- 7.6.6.5. Spain Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Denmark
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement Scenario
- 7.6.7.5. Denmark Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Competitive Scenario
- 7.6.8.3. Regulatory Framework
- 7.6.8.4. Reimbursement Scenario
- 7.6.8.5. Sweden Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.9. Norway
- 7.6.9.1. Key Country Dynamics
- 7.6.9.2. Competitive Scenario
- 7.6.9.3. Regulatory Framework
- 7.6.9.4. Reimbursement Scenario
- 7.6.9.5. Norway Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Asia Pacific Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Japan
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement Scenario
- 7.7.2.5. Japan Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. China
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement Scenario
- 7.7.3.5. China Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. India
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. Reimbursement Scenario
- 7.7.4.5. India Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Reimbursement Scenario
- 7.7.5.5. South Korea Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.6. Australia
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory Framework
- 7.7.6.4. Reimbursement Scenario
- 7.7.6.5. Australia Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1. Key Country Dynamics
- 7.7.7.2. Competitive Scenario
- 7.7.7.3. Regulatory Framework
- 7.7.7.4. Reimbursement Scenario
- 7.7.7.5. Thailand Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Latin America Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. Brazil
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement Scenario
- 7.8.2.5. Brazil Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Mexico
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement Scenario
- 7.8.3.5. Mexico Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. Argentina
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. Reimbursement Scenario
- 7.8.4.5. Argentina Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9. Middle East & Africa
- 7.9.1. Middle East & Africa Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.2. South Africa
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory Framework
- 7.9.2.4. Reimbursement Scenario
- 7.9.2.5. South Africa Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory Framework
- 7.9.3.4. Reimbursement Scenario
- 7.9.3.5. Egypt Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Competitive Scenario
- 7.9.4.3. Regulatory Framework
- 7.9.4.4. Reimbursement Scenario
- 7.9.4.5. UAE Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key Country Dynamics
- 7.9.5.2. Competitive Scenario
- 7.9.5.3. Regulatory Framework
- 7.9.5.4. Reimbursement Scenario
- 7.9.5.5. Kuwait Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. Key customers
- 8.3.2. Key company market share analysis, 2024
- 8.3.3. GE HealthCare
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Siemens Healthineers
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Koninklijke Philips N.V.
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Mediso
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Canon Medical Systems Corporation
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Cubresa Inc.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Shimadzu Corporation
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. United Imaging Healthcare Co
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook